Journal
MEDICAL CLINICS OF NORTH AMERICA
Volume 96, Issue 3, Pages 433-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2012.04.010
Keywords
Antibody deficiency; Immunoglobulin therapy; Common variable immunodeficiency; Hereditary angioedema; C1 inhibitor
Categories
Ask authors/readers for more resources
The 2 most commonly encountered primary immunodeficiency syndromes in adult practice are antibody deficiency disorders and hereditary angio-edema. Immunologic therapy for these disorders has significantly improved patient management. Therapy with immunoglobulin leads to improvement in overall quality of life. With increasing survival rates and decreasing levels of life-threatening infections in patients with primary antibody deficiencies, disease complications are more commonly encountered. Treatment of these complications with monoclonal antibody therapy seems promising and is likely to increase in the future. More recently, several additional agents have become available, including novel drugs targeted at different elements of the disease process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available